Recently, missense mutations in the transcriptional regulators KCTD1 and KCTD15 have been linked to syndromes in which ACC occurs, in addition to various other clinical abnormalities (7, 8). This evidence concerns the gene KCTD1 and adrenal cortex carcinoma.